Nautilus Biotechnology, Inc. financial data

Symbol
NAUT on Nasdaq
Industry
Laboratory Analytical Instruments
Location
2701 Eastlake Ave East, Seattle, Washington
Fiscal year end
December 31
Former names
ARYA Sciences Acquisition Corp III (to 6/8/2021)
Latest financial report
10-Q - Q2 2024 - Jul 30, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2K % -25.9%
Debt-to-equity 15.4 % +24.5%
Return On Equity -27.1 % -43.6%
Return On Assets -23.5 % -39.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 125M shares +0.38%
Common Stock, Shares, Outstanding 125M shares +0.38%
Entity Public Float 219M USD +44.1%
Common Stock, Value, Issued 13K USD +8.33%
Weighted Average Number of Shares Outstanding, Basic 125M shares +0.57%
Weighted Average Number of Shares Outstanding, Diluted 125M shares +0.57%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 49.8M USD +18.8%
General and Administrative Expense 31.6M USD +16.1%
Nonoperating Income (Expense) 11.8M USD +7.99%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -69.6M USD -19.6%
Earnings Per Share, Basic -0.55 USD/shares -19.6%
Earnings Per Share, Diluted -0.55 USD/shares -19.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 24.9M USD -65.5%
Cash, Cash Equivalents, and Short-term Investments 167M USD +2.51%
Assets, Current 171M USD +2.54%
Property, Plant and Equipment, Net 4.69M USD +12.4%
Operating Lease, Right-of-Use Asset 30.5M USD -12.1%
Other Assets, Noncurrent 1.18M USD -33.3%
Assets 273M USD -17.5%
Accounts Payable, Current 1.63M USD +33.1%
Employee-related Liabilities, Current 2.07M USD -1.29%
Liabilities, Current 8.68M USD +10%
Operating Lease, Liability, Noncurrent 28.8M USD -13.3%
Liabilities 37.5M USD -8.82%
Accumulated Other Comprehensive Income (Loss), Net of Tax -546K USD +77.1%
Retained Earnings (Accumulated Deficit) -239M USD -41.1%
Stockholders' Equity Attributable to Parent 235M USD -18.8%
Liabilities and Equity 273M USD -17.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -16.3M USD -29.9%
Net Cash Provided by (Used in) Financing Activities 245K USD +24400%
Net Cash Provided by (Used in) Investing Activities 22.4M USD
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 125M shares +0.38%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6.33M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 25.9M USD -64.9%
Deferred Tax Assets, Valuation Allowance 58.2M USD +41.3%
Deferred Tax Assets, Gross 66.9M USD +37%
Operating Lease, Liability 32.6M USD -10.6%
Depreciation 2.08M USD +46.4%
Payments to Acquire Property, Plant, and Equipment 647K USD -6.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -67.8M USD -13.3%
Lessee, Operating Lease, Liability, to be Paid 42.9M USD -13.9%
Property, Plant and Equipment, Gross 10.3M USD +30.5%
Operating Lease, Liability, Current 3.82M USD +17.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 6.87M USD -4.34%
Lessee, Operating Lease, Liability, to be Paid, Year One 7.18M USD +2.72%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 10.3M USD -22.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 6.89M USD +0.16%
Deferred Tax Assets, Operating Loss Carryforwards 21.6M USD +74.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 200M shares 0%
Unrecognized Tax Benefits 2.37M USD +53.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.82M USD -15.6%
Operating Lease, Payments 1.7M USD +41.7%
Additional Paid in Capital 475M USD +2.91%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 8.68M USD +14%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%